Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.
Sekine I, Nishiwaki Y, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Goto K, Kodama T, Eguchi K, Shinkai T, Tamura T, Ohe Y, Kunitoh H, Yoshimura K, Saijo N.
Sekine I, et al. Among authors: saijo n.
Br J Cancer. 2003 Mar 24;88(6):808-13. doi: 10.1038/sj.bjc.6600800.
Br J Cancer. 2003.
PMID: 12644814
Free PMC article.
Clinical Trial.